A reference standard (reference material) is an appropriately characterized, qualified material used as the benchmark for calibration, control, and comparison of analytical measurements across the product lifecycle. For new biologics, sponsors typically establish an in-house primary reference material from lot(s) representative of production and clinical materials, then qualify working (secondary) standards against it to maintain traceability. If suitable international or pharmacopoeial standards exist (e.g., WHO or Ph. Eur.), they may serve as primaries or traceability anchors. Regulators closely scrutinize establishment, qualification, and lifecycle management because reference standards underpin assay validity, specifications, and comparability.
Core functions
- Ensure lot-to-lot consistency: Provide the comparative standard for critical quality attributes (CQAs) over time.
- Calibrate and control assays: Serve as the calibration basis or control in quantitative methods (e.g., potency expressed relative to an assigned value such as 1.00 relative units or International Units [IU]).
- Support identity/structure/function: Enable identity tests and higher-order characterization during development and lifecycle changes.
- Maintain clinical linkage: Using a primary material representative of clinical/production lots preserves continuity to the product that demonstrated safety and efficacy.
Hierarchy and traceability
- Primary reference material (PRM): An appropriately characterized in-house material prepared from lot(s) representative of production and clinical materials; where available and appropriate, an international/national/pharmacopoeial standard may be used as the primary or for traceability (often with IU assignment).
- Working (secondary) reference standard (WRM): The routine standard used for release and stability testing; it is qualified (bridged) against the primary and periodically requalified to maintain the calibration hierarchy.
Qualification
Qualification goes beyond routine release testing and is fit-for-purpose for the intended analytical uses. It documents identity, purity/impurities, biological activity/potency (as applicable), assigned values (and, when relevant, uncertainty), and instructions for handling and use. For compendial standards, USP <11> covers proper use and storage expectations.
Lifecycle management
Reference standards are maintained under the Pharmaceutical Quality System with:
- a stability program to support expiry or re-test;
- requalification at defined intervals or after excursions/changes;
- timely replacement of working standards via bridging to the primary to keep the traceability chain intact. (Ph. Eur./EDQM apply analogous principles for Biological Reference Preparations and reference standard establishment per Ph. Eur. 5.12/ISO 17034.)
Regulatory Guidance
- ICH Q6B — Establish/qualify in-house primary from lot(s) representative of production and clinical materials; calibrate working standards against the primary; use international/national standards where appropriate.
- USP <11> — Proper use, storage, and handling of USP Reference Standards.
- WHO — Process for establishing International Biological Reference Preparations and assignment of IU. World Health OrganizationNIBSC
- Ph. Eur./EDQM — Purpose, establishment, and lifecycle of Ph. Eur. Reference Standards/BRPs (per 5.12; ISO 17034)